How Ebola Stocks Are Responding After the Outbreak in the Congo

Health and Healthcare

Published: May 12, 2017 11:50 am

Last Updated: January 12, 2020 12:03 pm

The World Health Organization (WHO) has confirmed a new outbreak of the Ebola virus in the Democratic Republic of Congo. So far at least one person has died after contracting the virus, in a lab-confirmed case. This is the first time in a while that the virus has resurfaced, and a few of the Ebola-related stocks are responding.

In the last major outbreak between 2014 and 2015, over 11,000 people died in West Africa, mainly in Guinea, Sierra Leone and Liberia.

24/7 Wall St. has taken a quick look at a few stocks that have an Ebola treatment in their portfolio or deal directly with the virus. We have included a recent trading history, as well as some color and the consensus analyst price target.

Sarepta Therapeutics Inc. (NASDAQ: SRPT) saw its shares up 1.5% at $34.02, with a consensus analyst price target of $60.88 and a 52-week trading range of $14.83 to $63.73. Year to date, shares are up 22%.

Lakeland Industries Inc. (NASDAQ: LAKE) shares are up over 8% at $11.94. The stock has a 52-week range of $8.00 to $11.95 and a consensus price target of $15.00. So far in 2017, excluding Friday’s move, the stock is up nearly 6%.

Novavax Inc. (NASDAQ: NVAX) shares are up 1% at $0.94, with a consensus price target of $3.48 and a 52-week range of $0.73 to $8.49. Year to date, the stock is down 26%.

NewLink Genetics Corp. (NASDAQ: NLNK) saw its stock jump 3.6% to $17.45, within a 52-week range of $9.41 to $25.17 and with a consensus price target of $26.80. In 2017, the stock is up 63%.

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) shares are up nearly 1% at $90.16. The stock has a 52-week range of $73.45 to $102.49. Year to date, the stock is up about 8%.

ALERT: Take This Retirement Quiz Now (Sponsored)

Take the quiz below to get matched with a financial advisor today.

Each advisor has been vetted by SmartAsset and is held to a fiduciary standard to act in your best interests.

Here’s how it works:
1. Answer SmartAsset advisor match quiz
2. Review your pre-screened matches at your leisure. Check out the advisors’ profiles.
3. Speak with advisors at no cost to you. Have an introductory call on the phone or introduction in person and choose whom to work with in the future

Take the retirement quiz right here.